The global influenza vaccine market is segmented into product type such as conjugate vaccines, live attenuated vaccines, inactivated and subunit vaccines, toxoid vaccines and recombinant vaccines. Increasing prevalence of influenza infection and growing awareness amongst the populations regarding influenza vaccines are fueling the demand for influenza vaccines across the globe. In addition to this, recombinant vaccines are approved for people of 18 years age and older including pregnant ... Read more